Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Analyze when to tilt toward stocks or bonds in retirement. A practical guide to selecting the right index mix for your goals.
22,082 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
NVIDIA CEO Jensen Huang predicts AI agents will infiltrate every function in every company, signaling a new phase for...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
Freddie Mac data show mortgage rates climbed to their highest level in almost four months, pushing the 30-year loan t...
Salesforce delivered a solid Q4 beat and announced a $50 billion buyback, but FY27 guidance disappointed investors. T...
Lamborghini posts record 2025 deliveries but trims profits as it shelves its all electric Lanzador. The luxury maker ...
BitFuFu reports 2025 results showing a shift toward cloud mining and a swing into loss as energy costs rise and Bitco...
Memes have evolved from jokes into a serious branding engine. In 2026, chuck norris never dies: anchors licensing dea...
Oracle has fallen this year as investors weigh legacy strengths against AI disruption. This guide breaks down the AI ...
A Global Partners LP COO sold nearly $740k worth of units in a short window. This article explains what insider trade...
U.S. companies are piloting forest ‘bathing’ breaks to curb stress and improve productivity. Early results show mood ...
Bitcoin surges in early trading after news that Iran postponed strikes. The move highlights how geopolitical headline...